Catalogo dei prodotti della ricerca

MELONI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.224
EU - Europa 4.004
AS - Asia 1.770
SA - Sud America 60
AF - Africa 39
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.108
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.125
IT - Italia 1.999
SG - Singapore 716
IN - India 609
SE - Svezia 511
CN - Cina 412
UA - Ucraina 396
FI - Finlandia 357
DE - Germania 177
GB - Regno Unito 124
RO - Romania 104
CA - Canada 87
IE - Irlanda 71
RU - Federazione Russa 62
FR - Francia 53
AR - Argentina 43
BG - Bulgaria 38
BE - Belgio 33
TG - Togo 26
CH - Svizzera 17
GR - Grecia 16
NL - Olanda 13
CL - Cile 12
MX - Messico 11
HK - Hong Kong 8
ZA - Sudafrica 8
DK - Danimarca 7
AU - Australia 6
ES - Italia 6
BR - Brasile 4
EU - Europa 4
JP - Giappone 4
SM - San Marino 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
KR - Corea 3
SC - Seychelles 3
TR - Turchia 3
CZ - Repubblica Ceca 2
IL - Israele 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
PL - Polonia 2
PT - Portogallo 2
AZ - Azerbaigian 1
CO - Colombia 1
CR - Costa Rica 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 16.108
Salva come PNG Salva come JPEG
Città #
Fairfield 1.397
Ashburn 860
Chandler 776
Woodbridge 705
Houston 576
Princeton 527
Seattle 524
Wilmington 522
Cambridge 468
Singapore 456
Ann Arbor 432
San Paolo di Civitate 348
Plano 332
Beijing 258
Des Moines 221
Rome 217
Lawrence 195
Boston 187
Millbury 177
Dearborn 137
Jacksonville 130
San Diego 125
Andover 101
Santa Clara 101
Southend 71
Milan 63
Toronto 58
Norwalk 56
Dublin 53
Bremen 46
Federal 41
Falls Church 38
Sofia 38
Bologna 37
San Mateo 34
Moscow 33
Boardman 31
Brussels 31
Hefei 31
Falkenstein 29
Helsinki 29
Lomé 26
New York 22
Ottawa 22
Florence 21
Bühl 20
Mannheim 19
Kunming 16
Torino 13
Buffalo 12
Grafing 12
Nanjing 12
Simi Valley 12
Indiana 11
Napoli 11
Genova 9
Guangzhou 9
Jinan 9
Mexico City 8
Brescia 7
Hong Kong 7
London 7
Menlo Park 7
Reggio Emilia 7
Shenyang 7
Springfield 7
Trumbull 7
Bern 6
Ferrara 6
Fuzhou 6
Laurel 6
Mountain View 6
Muizenberg 6
Pune 6
Santiago 6
Ancona 5
Bari 5
Chongqing 5
Dallas 5
Los Angeles 5
Montepulciano 5
Redmond 5
Riva 5
Venezia 5
Westminster 5
Alba 4
Caerano di San Marco 4
Cattolica 4
Cesena 4
Genoa 4
Jesi 4
Lauro 4
Potenza 4
Reston 4
San Jose 4
Auburn Hills 3
Aversa 3
Belpasso 3
Bisceglie 3
Calvizzano 3
Totale 10.964
Salva come PNG Salva come JPEG
Nome #
Terapia di salvataggio con il protocollo IEV seguito da chemioterapia ablativa e trapianto autologo in pazienti affetti da Hodgkin refrattari o in recidiva: risultati in 23 pazienti con età <18 anni alla diagnosi. 1.558
High dose cytarabine and idarubicin for the treatment of advanced acute lymphoblastic leukemia 281
Mitoxantrone, Etoposide e dosi intermedie di ARA-C (protocollo MEC) nel trattamento della leucemia acuta mieloide (LAM) del bambino refrattario o in recidiva 168
Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study. 110
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia 105
Haemato-oncology and burnout: an Italian survey 105
The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. 98
A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia 98
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: Evidence of NPM1 mutation stability 97
BAVC regimen and autograft for acute myelogenous leukemia in second complete remission 95
11.Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission 94
Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations. 91
Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study 88
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 88
Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia 85
Developing a European network for adult ALL. 84
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. 84
Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: A pilot study 83
Obesity and autologous stem cell transplantation in acute myeloid leukemia 81
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience 81
High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: Comparison with a historical control 80
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias 79
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation 78
Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide 78
Thrombotic thrombocytopenic purpura in the first trimester and successful pregnancy 77
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 77
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation 77
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia 75
BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results. 74
Ablative chemotherapy followed by peripheral-blood stem-cell reinfusion for chronic myelogenous leukemia chronic phase 73
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 73
Acute Erythroid Leukemia: A Distinctive Subtype of AML? Outcome and Prognostic Factors in Comparison with Non-M6 AML. The Gimema Experience. 73
Prospective Cytomegalovirus Monitoring During First-Line Chemotherapy in Patients With Acute Myeloid Leukemia 72
Acute myeloid leukemia and ischemic heart disease successful first line treatment with clofarabine as single agent. 72
Interleukin-3 priming in acute myeloid leukaemia patients 72
Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsia 72
Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation 72
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 72
Piperacillin/tazobactam/amikacin versus Piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. 71
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed 71
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 70
Long-term survival in adolescent and adult acute lymphoblastic leukemia 70
High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC-GIMEMA AML-12 trial 70
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) 69
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia 68
Type of relapse in 91 newly diagnosed MM patients treated with high dose chemotherapy followed by autologous stem cell transplantation. 68
Adolescent and adult acute lymphoblastic leukemia: Prognostic features and outcome of therapy. A study of 293 patients 68
Terapia della leucemia mieloide acuta del bambino resistente o in recidiva: risultati in 36 casi trattati con il protocollo MEC (Mitoxantrone, Etoposide e dosi intermedie di Ara-C). 68
The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase 67
Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement 66
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: A population-matched analysis 65
Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells. 65
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatement in patients enrolled in the GIMEMA LAL 0496 protocol. 64
Alte dosi di ARA-C + Idarubicina nel trattamento della leucemia linfoide acuta in fase avanzata 64
Ara-C, idarubicine and Gentuzumab ozogamicin (AIM) as salvage treatment in advanced acute myeloid leukemia patients 64
Cryptosporidiosis in patients with hematologic malignancies 64
Zoledronic acid-associated thrombotic thrombocytopenic purpura. 63
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. 63
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification 63
Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study. 63
High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation 63
Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia. 63
Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: Ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association 63
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multi-center phase III study 63
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience 63
Inherited thrombophilia in patients with thrombotic thrombocytopenic purpura 62
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administration 62
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH CHRONIC GRANULOCYTIC-LEUKEMIA (CGL) IN BLASTIC PHASE (BP) 62
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party 61
Vindesine in the treatment of refractory hematologic malignancies: A phase II study 61
Clofarabine-Based Regimen as Useful Bridge Therapy for Allogeneic Transplantation in Myeloid Blast Crisis of Philadelphia-Positive Chronic Myeloid Leukemia Resistant to Imatinib and Dasatinib 61
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): Phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial) 61
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients 61
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin 60
Vindesine in the treatment of refractory hematologic malignancies: A phase II study 60
Autologous bone marrow transplantation for patients with acute myelogenous leukemia in complete remission. 60
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10 60
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): A retrospective study from the European Cooperative Group for Blood and Marrow Transplantation 60
A new method to evaluate the prognostic value of response to prednisone pre-treatment in adult (15-60 yrs) patients with acute lymphoblastic leukemia: Results of the GIMEMA LAL 2000 study. 60
Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors 59
A multiplex reverse transcription-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 59
Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse: A single-centre experience 58
Autologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry. 58
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells 58
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT) 58
Neutropenic enterocolitis in patients with acute leukemia: Prognostic significance of bowel wall thickening detected by ultrasonography 58
Interleukin 2 in the management of hematologic malignancies. 58
Ice pops to prevent melphalan-induced stomatitis 58
High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) during Induction and Value of IL-2 during Maintenance in Acute Myelogenous Leukemia (AML): Impact of AraC Dose on Complete Remission Rate and Toxicity (Results on the first 1700 randomized patients of the AML-12 trial of EORTC and GIMEMA Leukemia Groups) 58
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period. 57
Protein expression of p15 and p21 plays an unfavorable prognostic role in adult acute lymphoblastic leukemia (ALL) patients independently of their gene promoter methylation status. 57
Juvenile chronic myeloid leukemia (CML): A single center 20-year experience. 57
Interleukin 2 treatment in acute myelogenous leukemia. 57
E-rosette positive acute lymphoblastic leukaemia in adolescents and adults 57
Autologous bone marrow transplantation for acute leukaemia in remission 57
FLT3 positive acute myeloid leukemia: A single center experience 57
Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia. 57
Idarubicin plus Cytosine-Arabinoside (ALL R-87 Protocol) in advanced acute lymphoblastic leukemia: the GIMEMA/AIEOP experience. 57
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian Study Group report 57
Peripheral T-Cell Lymphomas (PTCL) Treated With Or Without Upfront Autologous Stem Cell Transplantation: Results Of a Retrospective Single Center Analysis 57
Totale 8.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.073 0 0 0 0 0 391 416 375 316 280 204 91
2020/20211.012 118 130 49 111 55 39 39 118 123 90 103 37
2021/20223.252 23 212 286 228 463 92 69 258 219 300 337 765
2022/20233.326 841 707 92 343 295 442 57 137 261 24 95 32
2023/20241.194 95 162 32 47 44 51 24 281 4 173 116 165
2024/2025778 168 188 113 39 110 160 0 0 0 0 0 0
Totale 16.267